Go to Page # Page of 29
loading

Circulating Tumor DNA (ctDNA) in Bladder Cancer

 Alejo Rodriguez-Vida MD PhD
  8th-Mar-2019
Description: Bladder cancer is the 5th most common cancer. Urine and plasma from patients with bladder cancer may be monitored for diagnosis of progression and metastasis using mutation assays.
Views: 3113
Domain: Medical
Category: Biotech/Pharma
Contents:
ctDNA in Bladder Cancer
26/01/2019

Alejo Rodríguez-Vida MD PhD
Medical Oncology Department
Hospital del Mar, Barcelona

Introduction
NMIBC

MIBC

 Bladder cancer is the 5th most common cancer1
 70% of BC present as superficial (NMIBC)2,3:

 High recurrence rates require invasive follow-up3
 21% disease progression despite adequate follow-up in high grade
di ... See more

Recent Presentations

Tumor Plasticity in the Translational Space

Treat cancer & immune cell plasticity through coordinated approaches. Development of paradigm changing for local & systemic cancer therapies using innovative diagnostic tools.

Pierre Saintigny
16 July, 2019
Linda Tannenbaum
15 July, 2019
Wenhong Zhang
14 July, 2019